O2LINE
DEAD

Serial Number

98789168

Owner

PERSISTA BIO INC.

Attorney

Aleksandar Nikolic

First Use Date

Sep 19, 2024

Filing Date

Oct 7, 2024

Add to watchlist:

No watchlists yet
View on USPTO

O2LINE Trademark

Serial Number: 98789168

O2LINE is a trademark filed by PERSISTA BIO INC. on October 7, 2024. The trademark is classified under Class 10 (Medical Apparatus). The application is currently no longer active.

Owner Contact Info

PERSISTA BIO INC. (2 trademarks)

105 Lisa Place
Ithaca, NY 14850

Entity Type: 03

Trademark Details

Filing Date

October 7, 2024

Registration Date

Not Registered

First Use Anywhere

September 19, 2024

First Use in Commerce

September 19, 2024

Goods & Services

Surgical implants primarily consisting of artificial materials; surgical implants primarily comprising artificial materials; artificial tissues in the nature of surgical implants consisting of biological materials; biological tissues in the nature of surgical implants consisting of artificial materials; medical device surgical implants primarily comprised of artificial materials for cell therapy; medical device surgical implants primarily comprising artificial material for cell therapy; artificial biomaterial surgical implant for cell therapy; oxygen device surgical implants primarily comprising artificial material; oxygen device surgical implants primarily comprising artificial biomaterial; artificial biomaterial surgical implants for providing oxygen; artificial biomaterials drug delivery surgical implants; drug delivery surgical implants primarily comprising artificial materials; drug delivery surgical implants comprising artificial biomaterial; cell pouches; cell capsules

Filing History

ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Nov 4, 2025 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Nov 4, 2025 ABN2
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Jul 21, 2025 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Jul 21, 2025 XELR
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Apr 22, 2025 GNRN
NON-FINAL ACTION E-MAILED
Apr 22, 2025 GNRT
NON-FINAL ACTION WRITTEN
Apr 22, 2025 CNRT
USE AMENDMENT ACCEPTED
Apr 21, 2025 IUAA
ASSIGNED TO EXAMINER
Apr 10, 2025 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 9, 2025 NWOS
AMENDMENT TO USE PROCESSING COMPLETE
Oct 25, 2024 AUPC
USE AMENDMENT FILED
Oct 25, 2024 IUAF
TEAS AMENDMENT OF USE RECEIVED
Oct 25, 2024 EAAU
NEW APPLICATION ENTERED
Oct 7, 2024 NWAP